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Exploring the continuum in public response-styles to medical screening 
for disease. 
 
 
Introduction 
 
This paper analyses public responses to medical screening tests for 
disease. The conceptual approach in this paper draws on those approaches 
developed by scholarly thinkers who have addressed the genesis of human 
knowledge, the phenomena of disease/illness and the social meaning(s) 
arising from the public experience of illness. I will briefly describe 
some aspects from these approaches of significance for this paper. 
Firstly, the paper's approach to the genesis of human knowledge is based 
on a particular understanding about how knowledge can emerge from 
apparently differing methodologies which seem to be radically different. 
For example,  
 
"In works of scientific genius, it is reflection which draws the 
inner essence out of the simple fact. In humbler imaginative works 
of art, it is reverie which attires and embellishes the solitary 
fact. The complexity or simplicity of the work is irrelevant. The 
working of the spirit is the same for both." (1)  
 
Secondly, the approach to understanding the phenomena of health and 
illness is premised upon an ontology of caring with well-known historical 
antecedents. For example, 
 
"..the commonest exclamation which will be instantly made is - 
Would you do nothing, then, in cholera, fever, &c. ? - so deep 
rooted and universal is the conviction that to give medicine is to 
be doing some-thing or rather everything: to give air, warmth, 
cleanliness, &c., is to do nothing. The reply is, that in these and 
many other similar diseases the exact value of particular remedies 
is by no means ascertained, while there is universal experience as 
to the extreme importance of careful nursing in determining the 
issue of disease." (2) 
 
Thirdly, the paper takes a post-relativist stance on the social 
meaning(s) of disease (3). In this approach scientific statements are not 
seen as just mirroring nature's realities but as engaging phenomenal 
realities in highly ritualized ways which "talk-back" with "..a logic not 
wholly human and in ways richly generative of human meanings and social 
imperatives" (4). 
 
In this paper what is termed scientific knowledge is seen as involving 
ill understood processes which incorporate the 'natural' into human 
history for social purposes (5). In relation to scientific knowledge of 
AIDS (Acquired Immune Deficiency Syndrome) and human Retroviruses, this 
paper assumes that "contradictory evidence and widely divergent 
interpretations exist" within biomedical knowledge in terms of AIDS and 
the nature of Retroviruses, which are often not "..identifiable among 
categories of professional training" (6), like biomedical scientists and 
other experts who are practitioners of science and health care within our 
conformist institutions.  
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Public Response-Styles To Medical Screening Technology 
 
It seems that a crucial issue for conformist or mainstream medical 
practice is the public's response to medical biotechnology. This impacts 
the current debates on the value of medical screening technology in 
detecting disease. I will describe why this issue is an important one 
by using an approach which is similar to Langdon Winner's which takes 
account of the diversity in public responses to biotechnology and the 
specific artefacts of screening technology (7), like medical 'tests', 
which are often routinely applied to populations under the apparent 
guise of bettering the public health.  
 
This particular approach to medical biotechnology seriously considers 
these technologies by paying attention to their characteristics as 
technical objects, or artefacts, and the meaning those characteristics 
convey, perhaps imperceptibly, to the public who after all comprise the 
'end user' or consumer in our conformist health services. This approach 
appears useful because it can assist both public and professional to 
focus on and analyze the way medical tests aim to detect phenomena of 
ill-health solely in terms of cellular or molecular events (8). Armed 
with such technologies, health professionals are increasingly charged 
with marketing to a healthy public the message that they must '..come to 
us [health professionals], go through this procedure, and there will be a 
subsequent benefit'(9). In practice, screening 'tests' bring few 
benefits and are often imprecise (10); a fact now openly admitted by a 
British Government authority, the National Screening Committee (NSC). In 
1998, the NSC, charged with determining British standards in screening 
for all diseases, stated: 
 
      "Any [medical screening] test will find true and false positives, 
 and true and false negatives. An ideal test only finds true 
 positives and true negatives. In practice this is rarely possible, 
 and there is a trade-off between not missing real cases 
 (sensitivity) and not finding false cases (specificity). It is 
 because screening is rarely precise that much of the potential 
 for harm may come."(11).  
 
Given the above 'official' disclosure about the actual effectiveness of 
medical biotechnology, it is not difficult to work out why this issue is 
so political for modern health services and why the debates on modern 
biotechnology and its safety are increasingly common amongst the 
public; fuelled, of course, by an ever increasing, some say justified, 
public scepticism over the politics of science and the often sensational 
media coverage of such issues.  
 
In the United Kingdom for example, women have notably impacted the 
efficacy debates on Cervical Screening; parents have contested the 
received wisdom on Mass Childhood Immunization (12) and many groups are 
actively involved in the debates on Genetic Modification (GM) of foods. 
Also, scientific experts are seen to disagree on the 'correct' 
interpretation of scientific research as well as on how best to go about 
doing the research in the first place. This crisis point now reached in 
the public understanding of science is reflected in the current 
Eurocentric debates on what exactly are the criteria for an 'abnormal' 
cervical smear (13), what is really 'safe' about GM foods, or what 
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'really' causes 'BSE'/'new variant CJD' (14). These issues are also 
reflected in the British public's reduced level of trust in 
scientists, now reportedly lower than its trust in the police force, 
according to a recent opinion poll (15).  
 
To further illustrate the nature of these debates, I will describe two 
differing responses that suggest a spectrum, or perhaps, a continuum 
exists in public responses to medical biotechnology. I practice as a 
Registered Nurse (RN) in a Men's Health Clinic where young men often 
request sperm counts to measure their fertility without any intent to 
father children. The way that they can speak of this so-called 'simple' 
measure shows they actually perceive of it as a test of their 'virility'. 
This is one style of response, a form of social incorporation of the 
available technology; it can alter the so-called purely 'technical' 
meaning in line with the social or 'technosocial' realm of the particular 
individual; a mode of self-reinvention, or self-encounter, within a 
technological space itself perceived of as a 'socio-physical' environment 
- a form of techno-nature (16). This consumerist style of response may 
impact health care via public expectations and also maybe of utility to 
multinational corporations in future commercial design or manufacture of 
specific technologies. For example, in 1999 it was noted how public 
litigation in the United Kingdom had influenced the industrial 
development and production of medical devices to be marketed in the new 
Millenium (17).   
 
Another response-style can be more difficult for mainstream or conformist 
health services to appreciate. It can arise after experts' endorsement of 
the specificity and reliability of screening technologies, based upon 
scientists’ perceptions of consensus on disease causation (18). For 
example, the British Department of Health now says that HIV screening of 
all pregnant women, having no AIDS risk factors, is "better for your 
baby" (19). Their leaflet says "..you will have time to think about your 
choices for care and treatment during pregnancy and labour..you can 
decide whether or not you want to breastfeed."(20) Yet the biomedical 
literature also cites evidence that pharmaceutical treatment with the 
anti-HIV drug Zidovudine (AZT) damages human blood cells and bone marrow 
(21); AZT has not been tested in extensive Phase 3 clinical trials and is 
still considered toxic for both adults and foetus. Some pregnant women 
and biomedical scientists (22) now imply, what if 'better for baby' is 
really misguided coercion to swallow pharmaceutical 'poison'; perhaps 
(yet) another iatrogenic dose of Thalidomide or Stilboestrol, yet another 
bitter pill to swallow with who-knows-what real effects ? (23). 
 
For example, in Oregon United States in October 1998, Kathleen Tyson - a 
woman with no AIDS risk factors - tested HIV antibody-positive after 
mandatory HIV screening whilst pregnant (24). Tyson describes how by 
stealth she tried to evade perinatal transfusion of the AZT. Tyson's 
rebuttal to the doctors cited biomedical data on AZT's 'side-effects'; 
further data questioning HIV as the sole causative agent in AIDS; as well 
as querying the specificity and sensitivity of the HIV antibody test-
kits, patronisingly simplified for public consumption into a misnomer 
term, 'the HIV test', which incredibly manufacturers warn can test 
'false-positive' after a prior pregnancy (25). Following birth of what 
was Tyson's second child, later named Felix, the State of Oregon judged 
Tyson to be endangering his welfare and legally enforced the 
administration of AZT syrup to Felix. Tyson's second 'option', if she was 
non-compliant, meant the State took legal custody of Felix; hardly a 
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'choice' for any parent. Armed guards were reportedly posted outside her 
hospital room so insuring her compliance with court orders to medicate 
Felix and to stop Tyson from breastfeeding. In 1999, this scenario was 
presented to the United Nations Commission on the Human Rights of Women 
(26), cited as an example of abuse fuelled by the North American 
evangelical-style AIDS health legislation, the Ryan White Health Care 
Act, which promotes mandatory screening of all pregnant women for 
antibodies to HIV, via the stick-and-carrot of increased Federal 
government funding.  
 
Leaving aside the key issues over whether this increasingly common North 
American scenario represents either 'prevention-of-infection' or 
'biomedical fascism' (and its ethical dilemmas for health workers), what 
was different about Tyson's engagement with science concerned the 
manner in which her decision-making was quickly perceived of as 
dangerous, in context of the conformist and hegemonic medical opinion 
that her positive HIV antibody-test result was a 'true' positive, 
perceived by her infectious diseases paediatrician as overwhelmingly 
indicative of an infectious Retroviral agency. Tyson's resistant 
response-style incorporated so-called dissenting biomedical views on AIDS 
causation and treatment. It parallels current British parental opposition 
to Mass Childhood Immunization now waging a lengthy battle in the 
British High Court against the Department of Health for allegedly 
suppressing information on the effects of Measles, Mumps and Rubella 
vaccines (27). 
 
 
What is signified in AIDS technics? 
 
In his book The Birth of the Clinic, Michel Foucault analyzed the 
emergence of pathological anatomy. A key axiom in pathological anatomy 
was the postulation of an organic basis to the human experience of 
illness. In his analysis, Foucault postulated a medical or clinical gaze, 
le regard, at once perception and an active mode of seeing through which 
social objects like disease categories come into being. Foucault argued 
that this gaze was reorganized in the Modern episteme to inspect 
pathological reactions, not essential diseases, in order to seek the 
organic root of disease before visible lesions arose. Significant was 
"not what can be seen of these alterations, but what is determined by the 
place in which they develop" (28). The axiom was localization over 
visibility; whereby disease was considered to exist in space prior to 
existing for sight, in a spatialization of medical experience that 
defined a physiology of morbid anatomy. Our modern day technologies of 
screening for diseases like AIDS are epistemologically grounded in this 
notion of organic disease existing in space prior to its existence for 
sight.  
 
For example, in the case of AIDS and its so-called causative Retrovirus 
(human immunodeficiency virus type 1, HIV-1), antibodies to HIV are said 
to be localized within the patient's bodily fluids years before any AIDS-
related diseases are seen in the patient's body. Whilst the patient is 
said to appear well, the patient is also said to have the localized 
marker of infection, antibodies to HIV, which the approach of 
pathological anatomy determines as causative of the Syndrome of diseases 
now known as AIDS.  
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Modern technological medicine is developing more and more sophisticated 
algorithms for which to test for conditions like Cancer and for agents 
like prions on the assumption that a pathological/organic basis for 
disease always exists in an undetectable form without overtly evident 
signs or symptoms; thus, biomedicine aims to reduce all illness to its 
organic basis. The overarching axiom of all such modern medical screening 
technologies appears to be the detection of an occult spatialization of 
disease in the body before the reportage of symptoms and/or the emergence 
of signs. In this manner, antibodies to HIV are considered to represent 
a prodromal sign of possible and/or probable development of AIDS-related 
illness/disease. Using this conceptual understanding, it is possible to 
research the public understandings and experiences of the screening 
technologies utilized within the AIDS Clinic, like HIV antibody- 
tests, T-4 (CD4+) cell counts and the Viral Load tests, which are 
themselves artefacts of this reductionist approach arising inevitably 
from within our Modern episteme of pathological anatomy.  
 
The basis of such AIDS screening and testing technologies emanates from 
particular biomedical 'truths' and/or meanings surrounding the concept of 
exogenous Retroviral infection and its assumed clinical effect upon the 
human immune system. Long before the AIDS era, Mumford noted that the 
principles which develop any particular scientific method are often used 
to underpin technological invention (29). Mumford further stated: 
"Technics is a translation into appropriate, practical forms of the 
theoretic truths, implicit or formulated, anticipated or discovered, of 
science."(30). Given that modern biomedicine most often portrays 
AIDS as caused by HIV; the biochemical tests for HIV antibodies, T-4 
cells and Viral Load, together constitute AIDS technics, because they are 
translations into appropriate, practical forms of the theoretic truths 
implicit or formulated, anticipated or discovered, of the biomedical 
approach to AIDS as a Retroviral disease. In addition, Bijker et al. 
considered the difference between 'technology' and 'technics' as being 
like that between 'epistemology' and 'knowledge' (31). Similarly, whilst 
the technology of AIDS is premised on the episteme of pathological 
anatomy, the practical day to day biomedical knowledge of AIDS is 
premised on the application of AIDS technics, the biochemical tests for 
HIV antibodies, T-4 cells and Viral Load. Taken together, and within the 
AIDS Clinic, these screening tests are utilized in the medical 
determination of the pathological agency of the Retrovirus and its 
assumed effects upon the human immune system. Through analyzing 
individual's discourses on AIDS technics we may come to understand the 
hegemonic meaning(s) inherent within these screening technologies and how 
individuals formulate their own knowledge of AIDS premised upon their 
Inter-action with these theoretic 'truths' or hegemonic forms of knowing 
of AIDS as a Retroviral disease, wherein the concept of 'cure' is 
impossible by definition of the agency of exogenous infectious 
Retrovirus. In my research into the lived experience of AIDS, I have 
utilised Foucault's analysis of pathological anatomy as an artefact of 
the Modern episteme in order to develop a conceptual framework and 
methodology for analysing individuals' experiences of AIDS in relation to 
the routine screening, diagnostic and monitoring tests.  
 
In the following quote
1
 one individual refers to their T cell count 
following their description of their understanding of the meaning of the 
                                                          
1
 All real names attributed to the quotations cited in this paper have been 
changed. 
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positive test result for HIV antibodies. The individual focuses on the 
vagueness of the new context within which the test result has positioned 
him and his surveillance of his bodily symptoms together with the 
confounding nature of other factors like advancing years, 
       
"..skin things rashes, recurrent herpes attacks which appear to 
become increasingly virulent rather than less which is the normal 
progression and that's it really. Sometimes tiredness and fatigue. 
But then it's very difficult to put these in a context because you 
know I am not the energetic person I was ten years ago and that's 
maybe as much as to do with the fact that I am ten years older as 
anything else in a way it's part of the problem with HIV is that 
it's very difficult to grasp. But it's all rather vague things. 
There's nothing really specific and objective that I can grasp 
about it. I suppose one objective measure is something like 
declining T cells. But again these are sort of invisible things in 
your body." (Henry) 
 
In the above quote, the individual's experience of having received a 
positive test result for HIV antibodies was described as lacking in a 
'specific' and 'objective' frame of reference. One specific/objective 
frame of reference was spoken of as being the T cell count. This count 
was spoken of as enabling the person to 'grasp' something 'objective' 
about the experience of life following the HIV antibody test; perhaps, 
because the knowledge of the count involves the individual receiving a 
quantification of their own 'invisible' T cells. Thus, this particular 
'measure' is spoken of in terms which shows how it appears to facilitate 
a quantifiable delineation of life after the experience of testing for 
HIV antibodies. In the next quote, a similar reference is made in 
connection with the meaning of having tested positive for HIV 
antibodies, 
 
"Part of the problem with HIV is that it's very difficult to grasp 
because you have this enormous burden of a knowledge loaded on you 
about an underlying medical condition. Until there's something 
specific and real to react to its quite difficult to get a purchase 
on it and I suppose one objective measure is something like 
declining T cells." (Henry) 
 
In the above quote the individual speaks of the indeterminate nature of 
what is signified by a positive test result for HIV antibodies. This 
signification is spoken of in terms which are both problematic and 
contradictory. On the one hand it signifies something difficult to grasp 
whilst on the other hand it signifies an underlying 'condition' which is 
loaded upon the  individual. This ambiguous signification is spoken of in 
ethereal terms as something difficult to reckon with in any specific and 
real sense. One 'objective measure' of this 'underlying condition' is 
spoken of as knowing of a declining number of T cells in the body via the 
quantitation of the count. It enables the individual to react to 
something which is thus spoken of as being 'specific' and 'real'. This 
particular 'objective' knowledge is spoken of as facilitating 
the individuals' purchase on the key notion of there now existing, in a 
localized form (in the blood/bodily fluids), element(s) (antibodies) 
within their body's anatomy which are pathological (signify Retrovirus) 
and which is seemingly signified by the positive antibody test 
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result which had been previously spoken of as difficult to grasp. In the 
next quote, the knowledge of the falling T cell count is specifically 
referred to as eliciting a specific reaction,  
 
"..my T cells went down to 50 last year that was as I said a shock 
because whatever the arguments about what they actually mean 
there's something very objective about that I felt a need to react 
to and not in a perhaps, not in a.. and I have had to think what do 
I want to do with my life in the period of good health that I have 
left."(Henry) 
 
In the above quote, the speaker suggests that there are arguments over 
what is 'actually' signified by the T cell count. The speaker describes 
the experience of being told about falling numbers of T cells in the body 
in terms of shock. The speaker says that whatever their precise 
signification their so-called 'very objective' nature facilitates the 
feeling of need. In this way, knowledge of the count verbalized to the 
individual in the AIDS Clinic may generate or seed certain needs within 
the individual. This speaker's need is that of having to react to this 
particular biomedical knowledge. The terms in which this is spoken of are 
those of being 'shocked' and following this 'shock' having to think about 
the period of life which is remaining before death and dying. In this 
manner, the quantification of lifetime remaining which is signified by 
the T cell count may operate so as to reframe an individual's thinking 
more towards death and dying in a predetermined and powerful fashion. The 
latter is spoken of in terms which are less reminiscent of an 
individual's own particular experience of living and more reminiscent of 
the biomedical 'truth' of an incurable Retroviral disease. This 
psychological reframing of an individual's own thinking, via the technic 
as a translation of the hegemonic 'truth' of a Retroviral disease and as 
signifying biomedical knowledge of impending death, is further spoken of 
in the next quote, 
 
"..knowing that I've got fewer T cells than I had 2 years ago has a 
kind of psychological effect and in the last couple of counts which 
have been extremely low were a shock. I think they made me reassess 
what I am doing with my life in a way that surprises me really." 
(Henry) 
 
In the above quote the same speaker relates the shock of the knowledge of 
the count which signifies far more than its mere quantitation. Within the 
biomedical model of Retroviral AIDS a falling T cell count signifies 
impending illness and ultimately death and dying; and its psychological 
effect is that of making the individual reassess what they are doing in 
their own lifetime. It is noticeable that in the next quote from this 
particular speaker, who does not contest the signification of the test 
technology pertaining to HIV, the cause of the falling count is also 
hypothesized as being due to other than a Retroviral agency, 
 
"It's interesting that the massive fall in my T cells has happened 
over a period when I've been taking drugs specifically Acyclovir 
and it's not to say that it wouldn't have happened anyway but you 
do wonder to some extent." (Henry) 
 
In the above quote, the cause of the falling count is spoken of in 
equivocal terms as the speaker equivocally associates the lowered count 
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with taking prescribed medication. Such effort after meaning may lead to 
the generation of experiential knowledge of the technic which 
can compete or supersede the conformist or orthodox knowledge of the 
technic. In the following quote another speaker relates this engagement 
with alternative significations of the technic as being an inaccurate 
measure open to variation, 
 
"..because I've heard that it [CD4 count] is diurnal. I'd heard if 
you take it in the morning then take it in the evening of the same 
day and stuff like this. But the other reason for the morning thing 
too is [Doctor's name] said, and I knew and I knew what he was 
going to say, and I was waving pretty fists [at the Doctor who 
says] its of course like, "If you can get them off in the morning 
you can get them back the next      day because of the lab." I 
said, "O.K. I check that. I can buy that, but I still feel, I still 
believe that, it is these variations that are recorded." I said, 
"Because we all have biological clocks you know that rhythm changes 
if your biological rhythm changes according to the hour of the day 
and stuff like that I am sure everything else in your body is being 
affected at the same time." So you know, I didn't want to get 
Bolshie with him, because I do like him but I mean I couldn't. I 
said to him, "I don't buy everything you say", he said, "That's 
fair enough." (Andy) 
 
In the above quote, knowledge of the limitations in the test technology 
leads the speaker to openly question the conformist or orthodox 
signification of the technic. Subsequently the speaker's admission of not 
being swayed or influenced by the conformist or orthodox signification of 
this technic appears to have been acknowledged; in this sense, the 
speaker's dissentience appears to have been supported from within the 
AIDS Clinic. In all of the above quotes the technic is spoken of as 
embodying specific significations. In the next quote the technic is 
spoken of in terms indicating that certain significations actually 
constitute knowledge of apparent value for the speaker, 
 
"... but in a sense it is a shame that I didn't know then what I 
know now. I'm not quite sure what a difference it would have made 
maybe I would have approached things differently at an earlier 
stage." (Henry) 
 
In the above quote, it is ambiguous exactly how knowledge of the technic 
is valuable except that such knowledge now known was previously unknown, 
implying that the technic strategically or qualitatively alters one's 
life experience. In all of the above quotes the technic is spoken of as 
having an inherently ambiguous yet fundamental effect upon an 
individual's own decision-making processes. Part of this effect is spoken 
of in terms which indicate that it may reframe the individual's thinking 
towards death and dying. In this manner this particular technic may 
constitute a mode of biomedical terrorism as it can facilitate 
psychological trauma for individuals through its embodied significations 
of death and dying. However, as shown in the previous quote not all 
individuals are so fatally reframed by the technic in this manner. 
Similarly, the next quote also shows how this technic is spoken of in 
terms of its social as opposed to its biomedical signification, 
 
 
Page 10 of 17 
 
"You know I could just sort of have gone on and maybe had 2 cells T 
cells whatever you know. And it doesn't bother me. I don't 
particularly want to know unless he [the Doctor] wants to tell me. 
You know I had to know for my benefits and things. Because they had 
to know. Because I have to be signed off sick." (John) 
 
In the above quote the technic is spoken of as a form of knowledge 
important for the social welfare status of the speaker, as it may form 
part of the determination of their right to receive social welfare 
payments known colloquially in Britain as being "signed off" (meaning 
when one is medically judged as being unable to undertake employment due 
to sickness or suffering from a specific illness). Thus, the technic 
serves other more social and less biomedical functions such as providing 
'objective' (biomedical) evidence of the speaker's 'sickness' through 
the technic's particular embodied form of biomedical significations which 
are institutionalized within the conformist and biomedical definitions of 
AIDS as Retroviral disease. The offer of knowing about the technic made 
in the AIDS Clinic may be spoken of as having a particular imperative for 
the individual so that initially they feel they must know of it, as 
described in the next quote, 
 
"Oh to begin with yes because everybody thought it was important. 
But my CD[4+ T-4] count has been below 20 for about the last three 
years. I don't even ask what it is anymore. It's probably in minus 
figures now and I just realised the reason I was not interested in 
CD4 [T-4 cell] counts was from what I'd read professionally. And 
also, that the people who'd had CD4s of 400 had dropped dead and 
people who had CD4s of 20 and didn't even have an AIDS diagnosis. I 
mean one of my friends was diagnosed in 1983 and he hasn't got an 
AIDS diagnosis yet." (Jerry, health professional) 
 
In the above quote the speaker relates their understanding of the technic 
as having changed from one of a perceived significance to a perceived 
non-significance. This is spoken of as being due to the speaker's 
engagement with professional or 'expert' knowledge. This speaker 
further implies how such expert knowledge alone may not actually 
disqualify the embodied signification of this particular technic. From 
the above quote it appears that experiential knowledge may further 
disqualify the predictive biomedical signification embodied within this 
particular technic. Therefore, the imperative significations of this 
technic which may be inculcated within the AIDS Clinic can be effectively 
rendered unnecessary through experiential knowledge of the technic.  
 
The above analysis of one AIDS technic, the T cell count, has found that 
such a technic embodies biomedical significations which have some power 
to reframe an individual's psychological thoughts and decision-making. 
This power may be invested within the social context of the biomedical 
language and especially within the social context of the words as 
spoken by biomedical authorities. Through these specific significations 
as socially embodied or invested within this technic, an individual may 
be in turn shocked and affected by these specific significations. Such 
significations are transmitted via the social context of the spoken word 
to the individual in the AIDS Clinic by the agency of a practising 
biomedical authority, the orthodox or conformist doctor.  
 
Foucault conceived language as an "enigmatic multiplicity" that must be 
mastered (32). Thus, it is "in the holder of the discourse and more 
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profoundly still, in the possessor of the word, that language is gathered 
together in its entirety" (33). Thus, from the above analysis it is clear 
that non-experts may come to hold and possess certain biomedical 
significations of AIDS which are embodied within its technics or 
practical forms of knowing of its theoretic truths, like the HIV 
antibody-test and the T cell count. This engagement with biomedical 
knowledge within an emergent experiential knowledge of AIDS technics 
(itself played out through and within language), may enable an 
appropriation of the biomedical phenomenon of AIDS by those to whom the 
testing technology is applied/administered by conformist or orthodox 
health authorities like doctors. The above analysis, together with the 
above discussion of response-styles, all serve to show how public 
resistance may have the potential to subvert medical orthodoxy or 
conformity. Together these response-styles represent a form of public 
dissidence or dissentience from technological medicine; often 
acknowledged as such samizdat-style only within the columns of public 
action magazines, like CONTINUUM magazine (U.K.), INDEX ON CENSORSHIP 
(U.K.) and RETHINKING AIDS (U.S.A.), or from within other academic 
journals.  
 
 
 
Ramifications of dissentient discourse 
 
Unfortunately the particular form of public resistance discussed above in 
relation the antenatal screening and the more subtle resistance or 
dissentience seen in the analysis of the T cell count as technic, may run 
the precipitous gauntlet of coercion from conformist or orthodox 
health care experts and professionals. For those who respond like Tyson, 
the discourse on informed consent/prevention of infection reads more like 
enforced compliance/adherence, yet surprisingly the health professionals 
directly involved with Tyson (who may have done nothing verbally, 
behaviourally or politically in support of Tyson's position), could 
perceive they were 'truly' caring.  
 
How such disparity between the perceptions of 'patient' and 
'professional' arise is partly influenced by the prevailing ideology, in 
this case the 'science-related social currents' (34) which are 
institutionalizing mandatory HIV antibody screening as a 'standard of 
care' (sic) in the United States and likewise in the member states of the 
European Community (35). Ideological currents can have their own peculiar 
agnostic effect on our professional view about exactly what it is we, as 
health professionals, think we are doing to people during 
institutionalized care-giving. For example, German doctors interviewed 
after the Second World War said they perceived they were 'caring' for 
inpatients on the experimental wards of the Nazi's prison camps (36). 
Nurse Rivers, a central figure in recruitment of experimental subjects, 
reportedly thought she was instrumental in 'caring' for men from deprived 
communities throughout the unethical Tuskagee Syphilis experiment (37). 
Knowing that ideology underpins health professionals' actions and 
decision-making in institutional care does not exempt us from a duty to 
look beyond medical ideology and its dogmas. To be able to look beyond 
the ideology and the dogma means that to begin with, you, have to be 
willing to see. And to see alternatives to a status quo, you need to 
know, not where to look, but how to see. 
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For today's 'end user' of biotechnology who is aware of its pitfalls - 
the 'patient' now retitled in health promotion jargon as the 
'client/consumer' - scenarios like Tyson's stand as caveats if you like 
for pubic engagement with modern biotechnology, a consumer's warning, for 
those openly contesting dominant or hegemonic biomedical opinion that 
underwrites commercial development of ever newer medical biotechnologies. 
It is also implied that Tyson faced not only State-enforced medication 
but also ideological conformity to a perceived biomedical consensus, 
aided and abetted, by attending physicians and staff RNs directly 
involved (but by all?). Health services appeared to enforce conformity by 
duping Tyson into thinking 'informed consent' meant she could refuse 
administration of AZT to her child; in reality what was meant was 'no 
choice'. Just 'knowing' that biomedical science embodies differing views 
on drug efficacy, AIDS causation and the meaning of informed consent 
seemed to fail Tyson. However, the question may be posed does the old 
adage 'knowledge-is-power' no longer apply if one dissents from a medical 
orthodoxy ? Well, dissenting knowledge leads to the exercise of power 
through legal and other behavioural strategies, so the old adage kind of 
still stands.  
 
Differing public responses to medical biotechnology may indicate specific 
skills and knowledge are needed for health professionals to apprehend the 
nature and caveats of screening. If the education of health practitioners 
only attends to the technical tools and uncritically promotes 
biotechnical medicine, ignoring public apprehension over the design and 
arrangement of its biotechnology's artefacts, like screening tests, then 
health care practitioners may become more a-gnostic to that which is 
intellectually and practically crucial about modern biotechnology (38).  
 
In Britain, the professional body governing the Nursing and Midwifery 
professions, the United Kingdom Central Council (UKCC) for Nursing 
Midwifery and Health Visiting, determines that, "..each registered nurse, 
midwife and health visitor shall act, at all times, in such a manner as 
to..recognize and respect the uniqueness and dignity of each patient and 
client, and respond to their need for care, irrespective of their ethnic 
origin, religious beliefs, personal attributes, the nature of their 
health problems or any other factor." (39). Therefore it may be assumed 
that some health care professionals, like Registered Nurses, have a 
professional duty to respond to the public's needs irrespective of their 
response-style to medical biotechnology.  
 
From this assumption several implications may follow about the nature of 
the services which those professionals offer to the public, if an 
increasingly science-aware and consumer-active public is not to be 
further turned away from established or conformist health services. The 
'end consumer' of health services is the 'general public'. When consumers 
of care are discerning over biomedical science it must have a knock-on 
effect upon professional care providers and their educators. Professional 
practitioners and their educators need to be seen as accountable, open to 
scrutiny and mindful of the very real limitations of institutionalized 
science and the plural manner whereby the public can and do engage with 
the methodology and epistemology of science. This highlights a rationale 
for a more knowledgeable and reflexive awareness on behalf of health 
professionals about the problems, not just the so-called advantages, of 
modern biotechnology which have demanded greater and greater slices of 
the health budget in all members states within the European Community.  
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For example, in the case of increasing antibiotic resistance, British 
health authorities are now reluctantly beginning to see some benefit in 
other strategies: the non-prescription of antibiotics (now termed 
"watchful waiting"); government encouragement of the public to ensure a 
'normal' bacterial flora (meaning "free of chronic prescription 
antibiotic use"); the potential negative public effects of pharmaceutic 
corporations on health service research. The latter issues have served to 
demonstrate exactly how the British health authorities, since the Second 
World War and the founding of the British National Health Service in 
1948, have all fostered to a greater or lesser degree a blind faith in 
the efficacy of the 'magic [antibiotic] bullet' to alleviate, or even 
'cure', every common symptom from the sore throat to ear ache (40).  
 
The educators of health professionals also facilitate technical 'know-
how' on behalf of health practitioners within the context of promoting 
their caring and empathetic skills which are highly valued by the public. 
If the education of health practitioners is politically entrusted with 
only the crafting of 'bio-technical' health professionals, to oversee the 
public's 'compliance' or 'adherence' to biomedical prescriptions, this 
may only act to bolster existing norms and power relationships, 
benefiting powerful pharmaceutical corporations and medical researchers 
in the process.  
 
Although it is known that some health professionals, like Registered 
Nurses, want to stay abreast of developing technology whilst also wanting 
to promote humane caring (41), nevertheless in reality the professional 
carer working within the established or conformist health services too 
easily becomes just an uncritical prosthesis of medical biotechnology. 
Using the example of professional Nursing, the public's choice in terms 
of nursing personae may come to resemble little more than the 'choice' 
between, on the one hand the pharmaceutical straight-jacket of 'Nurse 
Ratchett' in Milos Forman's film One Flew Over The Cuckoo’s Nest, or on 
the other hand the humane prowess of 'Carol Hathaway', the Charge Nurse 
of the popular television programme ER, whose technical proficiency is 
often portrayed as secondary to her humane caring. The question is not 
just one of health services being politically charged with producing 
biotechnical Nurse Ratchett's or humane Carol Hathaway's, but more like 
how does the trade-off work between such power-laden and technically 
'skillful' personae in order for a knowledgeable and critical public to 
have a realistic choice over their own health care options in relation to 
their own beliefs and value systems?  
 
The education and training of health professionals is a tentative balance 
between public need and public expectation; and is subject to commercial 
market forces and political involvement from Governments (42). It may 
foster positive alliances between the public and health professionals, 
and encourage reflexive understanding on behalf of professionals of such 
issues (43); but these insightful developments should not be dependent 
upon enforcing public belief in the so-called 'rightness' of biotechnical 
options over other health choices which may be premised on differing 
beliefs and value systems to the end user. Health care professionals need 
to apprehend how differing ideologies engender power-laden conflicts; 
within which professionals can never be truly neutral. The education and 
training of health care professionals can reflect a philosophy of science 
which embraces public challenge, like those on AIDS published by 
CONTINUUM, as well as varying degrees of scientific uncertainty or 
scepticism.  
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In and of itself, public challenge, like that described above in relation 
to the signification of AIDS technics and to antenatal HIV screening 
tests, cannot preclude the role of professional agency in support of 
public decision-making to refuse medical biotechnology or facilitate 
health professionals' disregard of human rights or professionals' refusal 
to care for an increasingly knowledgeable and ever challenging public.  
 
The ambiguous nature of modern biotechnology and the diversity in the 
public engagement with its methods and epistemology must mean that whilst 
a dissenting public may reject modern biomedicine, health care 
professionals cannot themselves ethically to choose ignore those who 
dissent from modern biomedicine nor enforce public 'consent' to what 
appears to resemble a socially constructed consensus within the 
uncertainties of science. If so, then health care professionals are truly 
entering into a biomedical era more akin to Huxley's Brave New World or 
the agnostic modus operandi of those doctors and nurses who are often 
portrayed in the historical accounts from those who survived the 
internment camps during the Nazi era.  
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